Congenital urinary tract obstruction: the long view

Area of Science:

• Pediatric Nephrology
• Urology
• Developmental Biology

Background:

• Congenital urinary tract obstruction (UTO) is the primary identifiable cause of chronic kidney disease (CKD) in children.
• Prenatal ultrasonography often detects hydronephrosis, suggesting UTO, which can lead to reduced nephron number and bladder dysfunction.
• Severe UTO can impair fetal kidney growth, causing developmental and obstructive kidney injury.

Purpose of the Study:

• To review the causes, consequences, and management of congenital obstructive nephropathy in children.
• To highlight the limitations of current biomarkers and the need for improved diagnostic criteria for surgical intervention.
• To emphasize the importance of a multidisciplinary approach to patient care.

Main Methods:

• Review of existing literature on congenital urinary tract obstruction and its impact on kidney development and function.
• Discussion of animal models of obstructive kidney injury.
• Exploration of emerging diagnostic tools and therapeutic strategies.

Main Results:

• Congenital UTO leads to reduced nephron mass and can cause progressive kidney damage through ischemia, oxidative stress, and fibrosis.
• Current criteria for surgical correction of upper tract obstruction are inadequate due to a lack of effective biomarkers.
• The progression of CKD in affected children is highly variable.

Conclusions:

• Improved biomarkers, such as proteomics and MRI-based glomerular counting, are needed to guide treatment decisions.
• While angiotensin inhibitors have not proven effective, avoiding nephrotoxins and managing hypertension are important supportive measures.
• A seamless transition of care from prenatal to pediatric and adult urology/nephrology teams is essential for optimizing long-term outcomes.